Andrzej Pająk Selected Research

Type 2 Hdl Deficiency

1/2017

Metabolic syndrome and its components in Polish women of childbearing age: a nationwide study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrzej Pająk Research Topics

Disease

19	Hypertension (High Blood Pressure) 01/2021 - 01/2013
11	Acute Coronary Syndrome 08/2021 - 01/2011
8	Coronary Artery Disease (Coronary Atherosclerosis) 08/2021 - 01/2013
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2011
7	Myocardial Infarction 07/2020 - 09/2013
5	Obesity 07/2020 - 01/2014
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2020 - 10/2015
4	Coronary Disease (Coronary Heart Disease) 01/2022 - 04/2013
4	Abdominal Obesity 01/2021 - 06/2015
4	Overweight 01/2021 - 01/2015
4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2015
4	Hypercholesterolemia 12/2019 - 01/2016
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 09/2013
3	Stroke (Strokes) 07/2020 - 01/2018
2	Atrial Fibrillation 07/2020 - 01/2018
1	Glucose Intolerance 05/2021
1	Xerostomia 01/2021
1	Periodontitis 01/2021
1	Peripheral Arterial Disease 07/2020
1	Diabetes Mellitus 01/2020
1	Ischemic Stroke 10/2019
1	Dyslipidemias (Dyslipidemia) 10/2018
1	Isolated Systolic Hypertension 01/2018
1	Hemorrhage 01/2018
1	Periodontal Diseases (Periodontal Disease) 01/2018
1	Type 2 Hdl Deficiency 01/2017
1	Glucose Metabolism Disorders 01/2017
1	Neoplasms (Cancer) 03/2016
1	Hypertriglyceridemia 01/2016
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2016
1	Binge Drinking 11/2014
1	Heart Diseases (Heart Disease) 01/2013

Drug/Important Bio-Agent (IBA)

12	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 01/2014
8	LDL CholesterolIBA 01/2020 - 01/2014
7	LipidsIBA 08/2021 - 01/2016
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2021 - 01/2016
4	Triglycerides (Triacylglycerol)IBA 07/2020 - 06/2015
4	HDL CholesterolIBA 07/2020 - 01/2016
3	lipoprotein cholesterolIBA 01/2021 - 06/2017
3	CholesterolIBA 12/2019 - 01/2018
2	oxidized low density lipoproteinIBA 01/2020 - 01/2016
2	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 05/2019 - 01/2017
2	Coffee FDA Link 05/2018 - 10/2015
2	TeaIBA 05/2018 - 10/2015
2	cyclopropapyrroloindoleIBA 01/2018 - 01/2016
2	AntibodiesIBA 01/2018 - 01/2016
2	Gingipain Cysteine EndopeptidasesIBA 01/2018 - 01/2016
2	PolyphenolsIBA 06/2017 - 01/2017
2	PCSK9 InhibitorsIBA 01/2017 - 01/2016
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Pharmaceutical PreparationsIBA 10/2019
1	ORALIT (ORS)IBA 10/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2019
1	Oxygen (Dioxygen)IBA 05/2019
1	Sulfhydryl Compounds (Thiols)IBA 05/2019
1	AcidsIBA 10/2018
1	LignansIBA 07/2018
1	AnticoagulantsIBA 01/2018
1	Vitamin K FDA Link 01/2018
1	Insulin (Novolin)FDA Link 01/2017
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2017
1	Blood Glucose (Blood Sugar)IBA 01/2017
1	AntioxidantsIBA 01/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 06/2016
1	VitaminsIBA 03/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2016
1	beta Carotene (Betacarotene)FDA Link 03/2016
1	Vitamin E FDA LinkGeneric 03/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016
1	Ethanol (Ethyl Alcohol)IBA 11/2014

Therapy/Procedure

8	Secondary Prevention 01/2022 - 01/2013
8	Myocardial Revascularization 08/2021 - 01/2015
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 07/2014 - 09/2013
3	Percutaneous Coronary Intervention 07/2014 - 09/2013
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2011
2	Cardiac Rehabilitation 01/2021 - 06/2016
1	Therapeutics 01/2016
1	Treatment Delay 01/2011